AXILLARY SURGERY IN BREAST CANCER

Veronesi U, Saccozzi R, Del Vecchio M, Banfi A, Clemente C, De Lena M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med [Internet]. 1981 [acessado em 31 mar. 2015];305(1):6-11. Disponivel em: http://www.ncbi.nlm.nih.gov/pubmed/7015141. https://doi.org/10.1056/NEJM198107023050102

Fisher B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmond C, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med [Internet]. 1985 [acessado em 8 abr. 2015];312(11):665-73. REFERENCES Disponivel em: http://www.ncbi.nlm.nih.gov/pubmed/3883167. https://doi.org/10.1056/NEJM198503143121101

Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 2000;18(13):2553-9. https://doi.org/10.1200/JCO.2000.18.13.2553

Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection. JAMA. 2011;305(6):569-75. https://doi.org/10.1001/jama.2011.90

Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918-26. https://doi.org/10.1001/jama.2017.11470

Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJH, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981- 22023 AMAROS): A randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303- 10. http://dx.doi.org/10.1016/S1470-2045(14)70460-7

Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): A prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609-18. http://dx.doi.org/10.1016/S1470-2045(13)70166-9

Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer. JAMA. 2013;310(14):1455-61. http://doi.org/10.1001/jama.2013.278932

Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, et al. Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071. Ann Surg Oncol. 2013;20:S8-9. Disponivel em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324533/pdf/nihms598113.pdf

Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072-8. http://doi.org/10.1200/JCO.2015.64.0094

Donker M, Straver ME, Wesseling J, Loo CE, Schot M, Drukker CA, et al. Marking: axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients the MARI procedure. Ann Surg. 2015;261(2):378- 82. https://doi.org/10.1097/SLA.0000000000000558

Choy N, Lipson J, Porter C, Ozawa M, Kieryn A, Pal S, et al. Initial Results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients. Ann Surg Oncol. 2015;22(2):377-82. https://doi.org/10.1245/s10434-014-4034-6

Park S, Koo JS, Kim GM, Sohn J, Kim S Il, Cho YU, et al. Feasibility of charcoal tattooing of cytology-proven metastatic axillary lymph node at diagnosis and sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients. Cancer Res Treat. 2018;50(3):801-12. https://doi.org/10.4143/crt.2017.210

Patel R, MacKerricher W, Tsai J, Choy N, Lipson J, Ikeda D, et al. Pretreatment tattoo marking of suspicious axillary lymph nodes: reliability and correlation with sentinel lymph node. Ann Surg Oncol. 2019;26(8):2452-8. https://doi.org/10.1245/s10434-019-07419-3

Spautz CC. Avaliacao da taxa de identificacao do linfonodo previamente marcado com suspensao de carvao a 4% em pacientes com cancer de mama submetidas a quimioterapia neoadjuvante [dissertacao] [Internet]. Curitiba: Universidade Federal do Parana; 2017 [acessado em 07 de setembro de 2019]. Disponivel em: https://acervodigital.ufpr.br/bitstream/handle/1884/55038/R-D-CLEVERTONCESARSPAUTZ.pdf?sequence=1&isAllowed=y

Mamtani A, Barrio AV, King TA, Van Zee KJ, Plitas G, Pilewskie M, et al. How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study. Ann Surg Oncol. 2016;23(11):3467-74. https://doi.org/10.1245/s10434-016-5246-8